CHF 5633
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF 5633, covering 2021-06-23 to 2021-06-23. Get the full timeline:
Most recent: Clinical Trial Update: A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC) [Phase 2]